Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
?32.07

?32.07

 
WKN: A14NEW / Symbol: GEN / Name: Genesis / Stock / Healthcare Providers & Services / Small Cap /
Latest predictions
€32.07
07.11.25
-
buy
12.10.25
-
buy
€34.30
08.08.25
-
buy
€29.70
01.07.25
-
buy
Your prediction

Genesis Healthcare Inc. Stock

Currently there is a rather positive sentiment for Genesis Healthcare Inc. with 4 Buy predictions and 0 Sell predictions.
With a target price of 32 € there is potential for a 8321.05% increase which would mean more than doubling the current price of 0.38 € for Genesis Healthcare Inc..

Pros and Cons of Genesis Healthcare Inc. in the next few years

Pros
?
M***** P*******
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Genesis Healthcare Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Genesis Healthcare Inc. - - - - - - -
Addus Homecare Corp. -3.160% 6.145% -0.524% -20.833% 3.261% 1.604% -5.000%
Capital Senior Living Corp. -0.730% 0.000% 3.817% 33.333% 0.741% - -
Healthstream Inc. -0.520% -4.124% -9.709% -38.816% -4.615% -13.889% -7.000%

Comments

Prediction Buy
Perf. (%) -
Target price 32.068
Change
Ends at 07.11.26

Gen Digital (NASDAQ:GEN) had its price target raised by analysts at Evercore ISI from $35.00 to $37.00. They now have an "outperform" rating on the stock.
Ratings data for GEN provided by MarketBeat
Show more

Gen Digital (NASDAQ:GEN) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Ratings data for GEN provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -
Target price 34.300
Change
Ends at 08.08.26

Gen Digital Inc. (NASDAQ: GEN) had its price target raised by analysts at Wells Fargo & Company from $37.00 to $40.00. They now have an "overweight" rating on the stock.
Ratings data for GEN provided by MarketBeat
Show more

News

5 Energy Stocks That Could Benefit From the Genesis Mission: https://g.foolcdn.com/editorial/images/843478/atomic-energy.jpg
5 Energy Stocks That Could Benefit From the Genesis Mission

President Trump recently announced an executive order to initiate the Genesis Mission, a federal initiative under the Department of Energy, aimed at accelerating the development of artificial

What Are the 5 Top Artificial Intelligence (AI) Stocks to Buy Right Now?: https://g.foolcdn.com/editorial/images/844574/usa-flag-chip.jpg
What Are the 5 Top Artificial Intelligence (AI) Stocks to Buy Right Now?

It seems the artificial intelligence (AI) race has escalated once again following President Donald Trump's announcement that he has issued an executive order to launch Project Genesis. The

Genesis Energy (GEL) Q2 Revenue Down 12%
Genesis Energy (GEL) Q2 Revenue Down 12%

Genesis Energy (NYSE:GEL), a midstream energy infrastructure company focused on pipeline and transportation services in the Gulf of America, reported its second quarter 2025 earnings on July 31